-
HHS boosts smoking cessation, vaccinations with $137 million to states
WASHINGTON — The U.S. Department of Health and Human Services on Thursday awarded $137 million to states to boost prevention and public health initiatives, including support for smoking-cessation programs and vaccinations.
Awarded in nearly every state, the grants enhance state, tribal, local and territorial efforts to provide tobacco cessation services, strengthen public health laboratory and immunization services, prevent healthcare-associated infections, and provide comprehensive substance abuse prevention and treatment.
-
J&J drug approved for chronic pain
RARITAN, N.J. — The Food and Drug Administration has approved a drug made by Johnson & Johnson for treating chronic pain, a J&J subsidiary said Friday.
The FDA approved Janssen Pharmaceuticals' Nucynta ER (tapentadol) tablets, an extended-release drug for moderate to severe chronic pain in adults for whom a continuous, around-the-clock opioid analgesic is needed for an extended period of time.